Nitric oxide blocks nuclear factor-κB activation in alveolar macrophages

American Journal of Respiratory Cell and Molecular Biology

Volumn 21, Issue 3, 1999, Pages 311-316

  Raychaudhuri, Baisakhi ^a   Dweik, Raed ^a   Connors, Mary J ^a   Buhrow, Lisa ^a   Malur, Anagha ^a   Drazba, Judith ^a   Arroliga, Alejandro C ^a   Erzurum, Serpil C ^a   Kavuru, Mani S ^a   Thomassen, Mary Jane ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,2' (HYDROXYNITROSOHYDRAZONO)BIS ETHANAMINE; 2,2'-(HYDROXYNITROSOHYDRAZONO)BIS-ETHANAMINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITROSO DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTHMA; CASE CONTROL STUDY; CYTOLOGY; DOSE RESPONSE; DOWN REGULATION; HUMAN; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; METABOLISM; PHYSIOLOGY; PULMONARY HYPERTENSION;

ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; HYPERTENSION, PULMONARY; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; NF-KAPPA B; NITRIC OXIDE; NITROSO COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033192947     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.21.3.3611     Document Type: Article

References (22)

1. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. 1994. The biology of nitrogen oxides in the airways. Am. J. Respir. Crit. Care Med. 149:538-551.
2. Kobzik, L., D. S. Bredt, C. J. Lowenstein, J. M. Drazen, B. Gaston, D. Sugarbaker, and J. S. Stamler, 1993. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am. J. Respir. Cell Mol. Biol. 9:371-377.
3. Gustafsson, L. E. 1998. Exhaled nitric oxide as a marker in asthma. Eur. Respir. J. II(Suppl. 26):49-52.
4. Rubin, L. J. 1997. Primary pulmonary hypertension. N. Engl. J. Med. 336; 111-117.
5. Kaneko, F. T., A. C. Arroliga, R. A. Dweik, S. A. Comhair, D. Laskowski, R. Oppedisano, M. J. Thomassen, and S. C. Erzurum. 1998. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 158:917-923.
6. Alma, R., J. York, M. Boyars, S. Stafford, J. A. Grant, J. Lee, P. Forsythe, T. Sim, and N. Ida. 1996. Increased MCP-1, RANTES, and MIP-1-α in bronchoalveolar lavage fluid of allergic asthmatic patients. Am. J. Respir. Crit. Care Med. 153:1398-1404.
7. Lane, S. J., D. J. Cousins, A. R. Sousa, D. Z. Staynov, and T. H. Lee. 1997. Cytokines and growth factors in asthma. In Inhaled Glucocorticoids in Asthma. R. P. Schleimer, W. W. Busse, and P. M. O'Byrne, editors. Marcel Dekker, New York. 309-347.
8. Guo, F. H., K. Uetani, S. J. Haque, B. R. G. Williams, R. A. Dweik, F. B. J. M. Thunnissen, W. Calhoun, and S. C. Erzurum. 1997. Interferon-γ and interleukin-4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J. Clin. Invest. 100:829-838.
9. Kunkel, S. L., S. W. Chensue, N. W. Lukacs, and R. M. Strieter, 1997. Macrophage-derived cytokines in lung inflammation. In Lung Macrophages and Dendritic Cells in Health and Disease. M. F. Lipscomb and S. W. Russell, editors. Marcel Dekker, New York, 183-202.
10. Thomassen, M. J., L. T. Buhrow, M. J. Connors, F. T. Kaneko, S. C. Erzurum, and M. S. Kavuru. 1997. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 17:279-283.
11. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
12. American Thoracic Society. 1986. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
13. Dweik, R. A., D. Laskowski, H. M. Ahu-Soud, F. T. Kaneko, R. Hutte, D. J. Stuehr, and S. C., Erzurum. 1998. Nitric oxide synthesis in the lung. J. Clin. Invest. 101:660-666.
14. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
15. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299-302.
16. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
17. Peng, H., P. Libby, and J. K. Liao. 1995. Induction and stabilization of IκB-α by nitric oxide mediates inhibition of NF-κB. J. Biol. Chem. 270:14214-14219.
18. Lander, H. M., P. Schajpal, D. M. Levine, and A. Novogrodsky. 1993. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol. 150:1509-1516.
19. Wink, D. A., I. Hanbauer, M. B. Grisham, F. Laval, R. W. Nims, J. Laval, J. Cook, R. Pacclli, J. Liebmann, M. Krishna, P. C. Ford, and J. B. Mitchell. 1996. Chemical biology of nitric oxide: regulation and protective and toxic mechanisms. Curr. Top. Cell. Regul. 34:159-187.
20. Humbert, M., G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, and D. Emilie. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 151:1628-1631.
21. Kacmarck, R. M., R. Ripple, B. A. Cockrill, K. J. Bloch, W. M. Zapol, and D. C. Johnson. 1996. Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am. J. Respir. Crit. Care Med. 153:128-135.
22. Ricciardolo, F. L. M., P. Geppetti, A. Mistretta, J. A. Nadel, M. A. Sapienza, S. Bellofiore, and G. U. Di Maria. 1996. Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet 348:374-377.